What ICD-10 code should be used for a hepatic mass?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ICD-10 Code for Hepatic Mass

The appropriate ICD-10 code for a hepatic mass depends on whether the mass has been characterized as benign, malignant, or remains indeterminate:

Specific ICD-10 Codes Based on Mass Characterization

For Malignant Hepatic Masses:

  • C22.0 - Hepatocellular carcinoma (HCC) 1
  • C78.7 - Secondary malignant neoplasm of liver (for metastases)
  • C22.1 - Intrahepatic cholangiocarcinoma

For Benign Hepatic Masses:

  • D13.4 - Benign neoplasm of liver
  • K76.89 - Other specified diseases of liver (can be used for hemangiomas, focal nodular hyperplasia)

For Uncharacterized/Indeterminate Masses:

  • R93.2 - Abnormal findings on diagnostic imaging of liver and biliary tract (most appropriate for truly indeterminate lesions)
  • K76.9 - Liver disease, unspecified

Clinical Context Matters

The choice of code should align with the clinical workup status. Incidental liver masses are extremely common, with benign focal liver lesions found in up to 15% of adults 2. Common benign masses include cysts, hemangiomas, and focal nodular hyperplasia, while common malignant tumors include metastases and HCC 2.

Key Coding Considerations:

For initial detection before characterization: Use R93.2 when a mass is first identified but not yet characterized through appropriate imaging (contrast-enhanced CT or MRI).

After diagnostic workup: Once the mass has been characterized through multiphase contrast-enhanced CT (74-95% accuracy for differentiating benign from malignant) or MRI, use the specific diagnosis code 2.

For patients with known primary malignancy: If a hepatic mass is discovered in a patient with known extrahepatic cancer, consider C78.7 for metastatic disease, though characterization is still needed since benign lesions occur in nearly 30% of patients with primary malignancy 2.

Common Pitfalls to Avoid:

  • Do not use K76.82 - This code is specific for hepatic encephalopathy, not hepatic masses 3
  • Avoid premature coding - Don't assign a malignant code without proper imaging characterization or biopsy confirmation
  • Document risk factors - The presence of cirrhosis (K74.6), chronic hepatitis B, or other liver disease affects the differential diagnosis and may require additional codes 1, 4

The most defensible approach is to use R93.2 for an uncharacterized hepatic mass until definitive imaging or histopathology establishes a specific diagnosis, then code accordingly.

References

Research

Validity of administrative codes associated with cirrhosis in Sweden.

Scandinavian journal of gastroenterology, 2020

Guideline

acr appropriateness criteria® liver lesion-initial characterization.

Journal of the American College of Radiology, 2020

Research

Validation of ICD-10 Consensus Code Set for Cirrhosis Detection Using Electronic Health Records in an Asian Population.

JGH open : an open access journal of gastroenterology and hepatology, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.